Document Detail


Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study.
MedLine Citation:
PMID:  23335604     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AimsTricuspid regurgitation (TR) is common in patients with chronic heart failure (CHF) but its prognostic impact is unclear.Methods and resultsA total of 576 consecutive patients with CHF were prospectively included. The impact of moderate and severe (significant) TR on the combined endpoint death/heart transplantation/left ventricular-assist device implantation was assessed. Patients were followed for 5.8 ± 4.2 (maximum 14.4) years. Kaplan-Meier analysis showed a worse outcome of patients with significant TR (P < 0.0001). By multivariable analysis, amino terminal pro B-type natriuretic peptide (NT-proBNP) (P = 0.0028), systolic left ventricular function (LVF) (P = 0.0014), serum sodium, NYHA functional class, systolic blood pressure, right atrial size (all P = 0.0001), but not TR were significantly related with the outcome. However, as soon as the strong interaction between TR and LVF was included in the model, significant TR determined outcome as well (P = 0.0059). Therefore, in a second analysis patients were stratified for LVF. In patients with mildly or moderately impaired LVF, TR was significantly related with the outcome (HR: 1.368, CI: 1.070-1.748, P = 0.0125), whereas in patients with severely depressed LVF it was not (P = 0.1401). As a proof of concept, we additionally stratified patients according to serum NT-proBNP concentrations. In patients with NT-proBNP concentrations below the median (≤280 fmol/mL), TR was related with the outcome (HR: 2.512, CI: 1.127-5.597, P = 0.0242) but it was not in patients with NT-proBNP concentrations above the median (P = 0.3935).ConclusionThe prognostic impact of TR depends on the severity of CHF. While TR was significantly related with excess mortality in mild to moderate CHF, it provided no additive value in advanced disease when compared with established risk factors.
Authors:
Stephanie Neuhold; Martin Huelsmann; Elisabeth Pernicka; Alexandra Graf; Diana Bonderman; Christopher Adlbrecht; Thomas Binder; Gerald Maurer; Richard Pacher; Julia Mascherbauer
Related Documents :
10599054 - Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid ...
3663294 - Emergency department lumbar puncture: clinical application and utility of laboratory te...
23541094 - Presence of left atrial diverticula, accessory appendages, and normal variant pulmonary...
24316394 - Uric acid levels in obstructive sleep apnea patients with atrial fibrillation.
3824374 - Endotoxemia after abdominal surgery.
8872414 - Letter and category fluency in alzheimer's disease: a prognostic indicator of progression?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-18
Journal Detail:
Title:  European heart journal     Volume:  -     ISSN:  1522-9645     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Cardiology, Medical University of Vienna, Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in t...
Next Document:  A prospective case series of women with estrogen receptor-positive breast cancer: levels of tamoxife...